Literature DB >> 10811844

Predominant role for C5b-9 in renal ischemia/reperfusion injury.

W Zhou1, C A Farrar, K Abe, J R Pratt, J E Marsh, Y Wang, G L Stahl, S H Sacks.   

Abstract

Previous work has indicated that complement is a mediator of ischemia/reperfusion (I/R) injury. To investigate the components of complement responsible for this effect, we examined a model of renal I/R injury in C3-, C4-, C5-, and C6-deficient mice. We occluded the renal arteries and veins (40-58 minutes) and, after reperfusion (0-72 hours), assessed renal structural and functional injury. C3-, C5-, and C6-deficient mice were protected from renal I/R injury, whereas C4-deficient mice were not protected. C6-deficient mice treated with antibody to block C5a generation showed no additional protection from I/R injury. Reconstitution with C6 alone restored the I/R injury in C6-deficient mice. Tubular epithelial cells were the main structures damaged by complement-mediated attack, and, in contrast, the renal vessels were spared. Neutrophil infiltration and myeloperoxidase activity were reduced in C-deficient mouse kidney, but by a similar extent in C3-deficient and C6-deficient mice. We conclude that the membrane attack complex of complement (in which C5 and C6 participate) may account for the effect of complement on mouse renal I/R injury. Neither C5a-mediated neutrophil infiltration nor the classic pathway, in which C4 participates, appears to contribute to I/R injury in this model. By contrast with other organs, such as the heart, the primary effect of complement in the ischemic area is on the parenchymal cell rather than the vascular endothelial cell. The membrane attack complex of complement is a potential target for prevention of I/R injury in this model.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10811844      PMCID: PMC315463          DOI: 10.1172/JCI8621

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice.

Authors:  T N Mayadas; R C Johnson; H Rayburn; R O Hynes; D D Wagner
Journal:  Cell       Date:  1993-08-13       Impact factor: 41.582

Review 2.  The complement system in myocardial ischaemia/reperfusion injury.

Authors:  K S Kilgore; G S Friedrichs; J W Homeister; B R Lucchesi
Journal:  Cardiovasc Res       Date:  1994-04       Impact factor: 10.787

Review 3.  Complement receptors in neutrophils.

Authors:  H Sengeløv
Journal:  Crit Rev Immunol       Date:  1995       Impact factor: 2.214

4.  Mechanisms of ischemic acute renal failure.

Authors:  J V Bonventre
Journal:  Kidney Int       Date:  1993-05       Impact factor: 10.612

5.  Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis.

Authors:  C Troppmann; K J Gillingham; E Benedetti; P S Almond; R W Gruessner; J S Najarian; A J Matas
Journal:  Transplantation       Date:  1995-04-15       Impact factor: 4.939

6.  Alternative pathway activation of complement by cultured human proximal tubular epithelial cells.

Authors:  L Biancone; S David; V Della Pietra; G Montrucchio; V Cambi; G Camussi
Journal:  Kidney Int       Date:  1994-02       Impact factor: 10.612

Review 7.  The myocardial vasculature during ischemia and reperfusion: a target for injury and protection.

Authors:  D J Hearse; L Maxwell; C Saldanha; J B Gavin
Journal:  J Mol Cell Cardiol       Date:  1993-07       Impact factor: 5.000

8.  Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease.

Authors:  Y Wang; S A Rollins; J A Madri; L A Matis
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

9.  Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury.

Authors:  K J Kelly; W W Williams; R B Colvin; S M Meehan; T A Springer; J C Gutierrez-Ramos; J V Bonventre
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

10.  Localization of the complement regulatory proteins in the normal human kidney.

Authors:  S Ichida; Y Yuzawa; H Okada; K Yoshioka; S Matsuo
Journal:  Kidney Int       Date:  1994-07       Impact factor: 10.612

View more
  154 in total

1.  Kappa-opioid receptor agonist U50448H protects against renal ischemia-reperfusion injury in rats via activating the PI3K/Akt signaling pathway.

Authors:  Li-Jie Liu; Jian-Jun Yu; Xiao-Lin Xu
Journal:  Acta Pharmacol Sin       Date:  2017-08-03       Impact factor: 6.150

Review 2.  Complement in ischemia reperfusion injury.

Authors:  Niels C Riedemann; Peter A Ward
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

Review 3.  The effect of locally synthesised complement on acute renal allograft rejection.

Authors:  Steven Sacks; Wuding Zhou
Journal:  J Mol Med (Berl)       Date:  2003-06-25       Impact factor: 4.599

4.  Low-density array PCR analysis of reperfusion biopsies: an adjunct to histological analysis.

Authors:  Paolo Cravedi; Umberto Maggiore; Roslyn B Mannon
Journal:  Nephrol Dial Transplant       Date:  2010-05-26       Impact factor: 5.992

5.  New insight into the effects of heparinoids on complement inhibition by C1-inhibitor.

Authors:  F Poppelaars; J Damman; E L de Vrij; J G M Burgerhof; J Saye; M R Daha; H G Leuvenink; M E Uknis; M A J Seelen
Journal:  Clin Exp Immunol       Date:  2016-04-13       Impact factor: 4.330

Review 6.  Role of chemokines, innate and adaptive immunity.

Authors:  Kurt A Zimmerman; Katharina Hopp; Michal Mrug
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

Review 7.  Complement activation in progressive renal disease.

Authors:  Amy Fearn; Neil Stephen Sheerin
Journal:  World J Nephrol       Date:  2015-02-06

8.  IL-18 contributes to renal damage after ischemia-reperfusion.

Authors:  Huiling Wu; Melissa L Craft; Peng Wang; Kate R Wyburn; Gang Chen; Jin Ma; Brett Hambly; Steven J Chadban
Journal:  J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 10.121

9.  Anaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicity.

Authors:  Hao Pan; Zhoujun Shen; Partha Mukhopadhyay; Hua Wang; Pal Pacher; Xuebin Qin; Bin Gao
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

10.  The membrane attack complex (C5b-9) in liver cold ischemia and reperfusion injury.

Authors:  Constantino Fondevila; Xiu-Da Shen; Seiichiro Tsuchihashi; Yoichiro Uchida; Maria Cecilia Freitas; Bibo Ke; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Liver Transpl       Date:  2008-08       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.